200 related articles for article (PubMed ID: 34123815)
1. Prognostic Prediction of Cytogenetically Normal Acute Myeloid Leukemia Based on a Gene Expression Model.
Yang L; Zhang H; Yang X; Lu T; Ma S; Cheng H; Yen K; Cheng T
Front Oncol; 2021; 11():659201. PubMed ID: 34123815
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
[TBL] [Abstract][Full Text] [Related]
3. A 6-Membrane Protein Gene score for prognostic prediction of cytogenetically normal acute myeloid leukemia in multiple cohorts.
Lin SY; Miao YR; Hu FF; Hu H; Zhang Q; Li Q; Chen Z; Guo AY
J Cancer; 2020; 11(1):251-259. PubMed ID: 31892991
[No Abstract] [Full Text] [Related]
4. A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia.
Deng C; Zeng T; Zhu P; Zhao S; Huang Z; Huang W; Zhang W; Huang X; Fu L
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10015-10025. PubMed ID: 37258721
[TBL] [Abstract][Full Text] [Related]
5. DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets.
Gabellier L; Bret C; Bossis G; Cartron G; Moreaux J
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33036275
[TBL] [Abstract][Full Text] [Related]
6. Aberrant
Huang S; Huang Z; Chen P; Feng C
Front Oncol; 2020; 10():1648. PubMed ID: 33014825
[No Abstract] [Full Text] [Related]
7. The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia.
Cao L; Zhang W; Liu X; Yang P; Wang J; Hu K; Zhang X; Liu W; He X; Jing H; Yuan X
Sci Rep; 2019 Nov; 9(1):16991. PubMed ID: 31740742
[TBL] [Abstract][Full Text] [Related]
8. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
[TBL] [Abstract][Full Text] [Related]
9. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
Shi JL; Fu L; Wang WD
Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
[TBL] [Abstract][Full Text] [Related]
10. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia.
Fu L; Shi J; Hu K; Wang J; Wang W; Ke X
Oncotarget; 2015 Apr; 6(10):8144-54. PubMed ID: 25924238
[TBL] [Abstract][Full Text] [Related]
12. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y
Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658
[TBL] [Abstract][Full Text] [Related]
13. High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.
Shi J; Fu H; Jia Z; He K; Fu L; Wang W
EBioMedicine; 2016 Dec; 14():55-64. PubMed ID: 27916548
[TBL] [Abstract][Full Text] [Related]
14. High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia.
Fu L; Fu H; Tian L; Xu K; Hu K; Wang J; Wang J; Jing H; Shi J; Ke X
Oncotarget; 2016 Mar; 7(13):15828-39. PubMed ID: 26910834
[TBL] [Abstract][Full Text] [Related]
15. Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients.
Zhu R; Tao H; Lin W; Tang L; Hu Y
Front Oncol; 2020; 10():574939. PubMed ID: 33330048
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients.
Tsai CH; Yao CY; Tien FM; Tang JL; Kuo YY; Chiu YC; Lin CC; Tseng MH; Peng YL; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF
EBioMedicine; 2019 Feb; 40():240-250. PubMed ID: 30662003
[TBL] [Abstract][Full Text] [Related]
17. A new prognostic risk model for acute myeloid leukemia patients based on telomere-related genes.
Zhang F; Du H; Hu C; Song Y
Leuk Res; 2023 Dec; 135():107404. PubMed ID: 37844405
[TBL] [Abstract][Full Text] [Related]
18. Acidic leucine-rich nuclear phosphoprotein-32A expression contributes to adverse outcome in acute myeloid leukemia.
Huang S; Huang Z; Ma C; Luo L; Li YF; Wu YL; Ren Y; Feng C
Ann Transl Med; 2020 Mar; 8(6):345. PubMed ID: 32355789
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.
Ghanem H; Tank N; Tabbara IA
Am J Hematol; 2012 Jan; 87(1):69-77. PubMed ID: 22072438
[TBL] [Abstract][Full Text] [Related]
20. A Novel Scoring System for Risk Assessment of Elderly Patients With Cytogenetically Normal Acute Myeloid Leukemia Based on Expression of Three AQP1 DNA Methylation-Associated Genes.
Yin X; Huang H; Huang S; Xu A; Fan F; Luo S; Yan H; Chen L; Sun C; Hu Y
Front Oncol; 2020; 10():566. PubMed ID: 32373535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
